ELV Elevance Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ELV

Price (delayed)

$417.89

Market cap

$90.75B

P/E Ratio

17.68

Dividend/share

$6.86

EPS

$23.64

Enterprise value

$112.93B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 45

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately ...

Highlights
The company's revenue rose by 9% YoY
The equity has increased by 3.3% YoY
ELV's P/E is 26% above its last 4 quarters average of 14.0 and 2.8% above its 5-year quarterly average of 17.2
Elevance Health's net income has decreased by 11% YoY and by 7% QoQ
Sector: Healthcare
Industry: Healthcare Plans
Website: http://www.antheminc.com
Peers: OSCR PFG

Key stats

What are the main financial stats of ELV

ELV stock price

How has the Elevance Health stock price performed over time
Intraday
0.41%
1 week
7.89%
1 month
7.42%
1 year
19.31%
YTD
19.21%
QTD
8.06%

Financial performance

How have Elevance Health's revenue and profit performed over time
Revenue
$200.42B
Gross profit
$30.23B
Operating income
$7.63B
Net income
$5.24B
Gross margin
15.1%
Net margin
2.6%
The operating margin has declined by 22% year-on-year and by 7% since the previous quarter
Elevance Health's net margin has decreased by 19% YoY and by 7% from the previous quarter
The operating income has contracted by 15% YoY and by 6% from the previous quarter
Elevance Health's net income has decreased by 11% YoY and by 7% QoQ

Price vs fundamentals

How does ELV's price correlate with its fundamentals

Growth

What is Elevance Health's growth rate over time

Valuation

What is Elevance Health stock price valuation
ELV P/E details
P/E
17.68
P/B
2.1
P/S
0.46
EV/EBIT
14.79
EV/EBITDA
12.32
EV/Sales
0.56
ELV's P/E is 26% above its last 4 quarters average of 14.0 and 2.8% above its 5-year quarterly average of 17.2
Elevance Health's EPS has decreased by 8% YoY and by 6% QoQ
ELV's price to book (P/B) is 24% higher than its last 4 quarters average of 1.7 but 19% lower than its 5-year quarterly average of 2.6
The equity has increased by 3.3% YoY
ELV's P/S is 23% below its 5-year quarterly average of 0.6 but 15% above its last 4 quarters average of 0.4
The company's revenue rose by 9% YoY

Efficiency

How efficient is Elevance Health business performance
Elevance Health's return on sales has decreased by 22% YoY and by 7% QoQ
Elevance Health's ROIC has decreased by 22% YoY and by 8% from the previous quarter
Elevance Health's return on assets has decreased by 16% YoY and by 9% QoQ
ELV's ROE is down by 14% YoY and by 8% QoQ

Dividends

What is ELV's dividend history
Dividend details
DPS
$6.86
Dividend yield
1.64%
Payout ratio
29%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Elevance Health financials performed over time
The total assets is 54% higher than the total liabilities
The total liabilities is up by 6% year-on-year and by 6% since the previous quarter
ELV's quick ratio is down by 6% since the previous quarter
Elevance Health's debt is 27% less than its equity
Elevance Health's debt has increased by 6% YoY
The equity has increased by 3.3% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.